149 related articles for article (PubMed ID: 32300936)
21. Hemophagocytic lymphohistiocytosis associated with the use of lamotrigine.
Kim T; Kulick CG; Kortepeter CM; Brinker A; Waldron P
Neurology; 2019 May; 92(21):e2401-e2405. PubMed ID: 30996059
[TBL] [Abstract][Full Text] [Related]
22. Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel Diseases.
Borren NZ; Luther J; Colizzo FP; Garber JG; Khalili H; Ananthakrishnan AN
J Crohns Colitis; 2019 Aug; 13(8):990-995. PubMed ID: 30888405
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
24. Hemophagocytic Lymphohistiocytosis in the Elderly.
Altook R; Ruzieh M; Singh A; Alamoudi W; Moussa Z; Alim H; Safi F; Duggan J
Am J Med Sci; 2019 Jan; 357(1):67-74. PubMed ID: 30278875
[TBL] [Abstract][Full Text] [Related]
25. Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol.
Yiu TH; Ko Y; Pudipeddi A; Natale P; Leong RW
BMJ Open; 2023 Oct; 13(10):e073071. PubMed ID: 37788929
[TBL] [Abstract][Full Text] [Related]
26. Malignancy associated hemophagocytic lymphohistiocytosis in children.
Singh A; Dawman L; Seth R
J Cancer Res Ther; 2018; 14(3):559-562. PubMed ID: 29893316
[TBL] [Abstract][Full Text] [Related]
27. Infections in inflammatory bowel disease patients on immunomodulator and biologic therapy are not associated with high serum drug levels.
Gazelakis K; Chu I; Martin C; Sparrow MP
Intern Med J; 2024 Jan; 54(1):139-148. PubMed ID: 37151186
[TBL] [Abstract][Full Text] [Related]
28. Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs.
Na SY; Kim YS
Korean J Intern Med; 2022 Sep; 37(5):906-919. PubMed ID: 35945034
[TBL] [Abstract][Full Text] [Related]
29. Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease.
George LA; Gadani A; Cross RK; Jambaulikar G; Ghazi LJ
Dig Dis Sci; 2015 Nov; 60(11):3424-30. PubMed ID: 26115749
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case Series.
Phillips F; Verstockt B; Ribaldone DG; Guerra I; Teich N; Katsanos K; Filip R; Molner T; Karmiris K;
J Crohns Colitis; 2022 Mar; 16(3):500-505. PubMed ID: 34508639
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis.
Singh S; Murad MH; Fumery M; Sedano R; Jairath V; Panaccione R; Sandborn WJ; Ma C
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1002-1014. PubMed ID: 34688373
[TBL] [Abstract][Full Text] [Related]
32. Lamotrigine-associated hemophagocytic lymphohistiocytosis.
Suleman N; Ozdemirli M; Weisman D
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33408106
[TBL] [Abstract][Full Text] [Related]
33. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
Papamichael K; Cheifetz AS; Melmed GY; Irving PM; Vande Casteele N; Kozuch PL; Raffals LE; Baidoo L; Bressler B; Devlin SM; Jones J; Kaplan GG; Sparrow MP; Velayos FS; Ullman T; Siegel CA
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1655-1668.e3. PubMed ID: 30928454
[TBL] [Abstract][Full Text] [Related]
34. Hemophagocytic Lymphohistiocytosis mimics many common conditions: case series and review of literature.
Akenroye AT; Madan N; Mohammadi F; Leider J
Eur Ann Allergy Clin Immunol; 2017 Jan; 49(1):31-41. PubMed ID: 28120605
[No Abstract] [Full Text] [Related]
35. Severe complication during remission of Crohn's disease: hemophagocytic lymphohistiocytosis due to acute cytomegalovirus infection.
Miechowiecki J; Stainer W; Wallner G; Tuppy H; Aichinger W; Prammer W; Kirchgatterer A
Z Gastroenterol; 2018 Mar; 56(3):259-263. PubMed ID: 29529681
[TBL] [Abstract][Full Text] [Related]
36. Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study.
Holmer AK; Luo J; Russ KB; Park S; Yang JY; Ertem F; Dueker J; Nguyen V; Hong S; Zenger C; Axelrad JE; Sofia A; Petrov JC; Al-Bawardy B; Fudman DI; Llano E; Dailey J; Jangi S; Khakoo N; Damas OM; Barnes EL; Scott FI; Ungaro RC; Singh S;
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1598-1606.e5. PubMed ID: 36642291
[TBL] [Abstract][Full Text] [Related]
37. Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.
Dulai PS; Thompson KD; Blunt HB; Dubinsky MC; Siegel CA
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1443-51; quiz e88-9. PubMed ID: 24462626
[TBL] [Abstract][Full Text] [Related]
38. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy.
Griffin G; Shenoi S; Hughes GC
Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101515. PubMed ID: 32387063
[TBL] [Abstract][Full Text] [Related]
39. Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis.
Xie W; Xiao S; Huang H; Zhang Z
Front Immunol; 2022; 13():847160. PubMed ID: 35300336
[TBL] [Abstract][Full Text] [Related]
40. Hemophagocytic lymphohistiocytosis in a patient with Goodpasture's syndrome: a rare clinical association.
Basnet A; Cholankeril MR
Am J Case Rep; 2014 Oct; 15():431-6. PubMed ID: 25284133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
